Integral Molecular is a research-driven biotechnology company creating innovative technologies and therapeutic antibodies for under-exploited membrane protein targets, including GPCRs, ion channels, transporters, and viral envelopes.

February 20, 2013

Patent for Nano-scale Detection of Ion Channel Function in Lipoparticles

PHILADELPHIA–(BUSINESS WIRE)–Integral Molecular, Inc., a leader in membrane protein reagents and services, announces a patent allowance covering its technology for cell-free detection of ion channel function. […]
December 3, 2012

Integral Molecular and IntelliCyt Corporation Announce Co-marketing Collaboration

PHILADELPHIA–(BUSINESS WIRE)–Integral Molecular and IntelliCyt Corporation today announced the formation of a collaborative marketing alliance to co-promote Integral’s Shotgun Mutagenesis protein mapping and engineering platform and […]
November 15, 2012

Integral Molecular and Crystal Bioscience Announce Research Collaboration to Develop Novel GPCR and Ion Channel Antibodies

PHILADELPHIA–(BUSINESS WIRE)–Crystal Bioscience and Integral Molecular have launched a research collaboration to generate panels of chicken monoclonal antibodies against undisclosed therapeutic GPCR and ion channel targets. […]
May 3, 2012

Integral Molecular Announces Patent Allowance for its Membrane Protein Lipoparticle Technology

PHILADELPHIA–(BUSINESS WIRE)–Integral Molecular, a leader in membrane protein reagents and services, announces the issuance of a key patent protecting its methodology for generating Lipoparticles, which provide […]
April 25, 2012

Integral Molecular Announces Lipoparticle Distribution in Japan by Funakoshi

PHILADELPHIA–(BUSINESS WIRE)–Integral Molecular, a leader in membrane protein reagents and services, announces an exclusive agreement with Funakoshi for the distribution of Integral Molecular’s catalog of concentrated […]
November 15, 2010

Integral Molecular to Expand its Headquarters at the Science Center in Philadelphia

PHILADELPHIA, PA, November 15, 2010 — Integral Molecular, Inc. and the University City Science Center announced today that Integral Molecular has signed a 10-year lease at […]
July 27, 2010

Integral Molecular Announces Key Patent Issued on Lipoparticle Technology for Deriving High Concentrations of Cell-free Membrane Proteins

PHILADELPHIA–(BUSINESS WIRE)–Integral Molecular, Inc. today announced the issuance of a key patent covering its technology for deriving high concentrations of membrane proteins. The patent, issued by […]
November 3, 2009

Integral Molecular Awarded $9.1 Million Contract from NIAID to Map Epitopes on Viral Pathogens using Shotgun Mutagenesis Mapping Technology

PHILADELPHIA–(BUSINESS WIRE)–Integral Molecular, Inc. has been selected to receive a five year, $9.1 million contract from the National Institute of Allergy and Infectious Disease (NIAID), part […]